Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOPAMINE vs DOSTARLIMAB-GXLY: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOPAMINE vs DOSTARLIMAB-GXLY: Safety Overview

Metric DOPAMINE DOSTARLIMAB-GXLY
Total FAERS Reports 942 504
Deaths Reported 325 55
Death Rate 34.5% 10.9%
Hospitalizations 496 126
Average Patient Age 44.7 yrs 67.4 yrs
% Female Patients 48.6% 92.7%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer HF Acquisition Co LLC, DBA HealthFirst N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Prescription